These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 32068093)

  • 21. Effect of granulocyte colony-stimulating factor in experimental methicillin resistant Staphylococcus aureus sepsis.
    Alp E; Gozukucuk S; Canoz O; Kirmaci B; Doganay M
    BMC Infect Dis; 2004 Oct; 4():43. PubMed ID: 15491501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination Therapy With Vancomycin and Ceftaroline for Refractory Methicillin-resistant Staphylococcus aureus Bacteremia: A Case Series.
    Gritsenko D; Fedorenko M; Ruhe JJ; Altshuler J
    Clin Ther; 2017 Jan; 39(1):212-218. PubMed ID: 28038791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Ceftaroline, Vancomycin, Gentamicin, Macrolides, and Ciprofloxacin against Methicillin-Resistant
    ElFeky DS; Awad AR; Elshobaky MA; Elawady BA
    Surg Infect (Larchmt); 2020 Mar; 21(2):150-157. PubMed ID: 31513456
    [No Abstract]   [Full Text] [Related]  

  • 24. Dalbavancin Alone and in Combination with Ceftaroline against Four Different Phenotypes of
    Kebriaei R; Rice SA; Stamper KC; Rybak MJ
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methicillin-resistant Staphylococcus aureus bacteraemia and endocarditis treated with ceftaroline salvage therapy.
    Ho TT; Cadena J; Childs LM; Gonzalez-Velez M; Lewis JS
    J Antimicrob Chemother; 2012 May; 67(5):1267-70. PubMed ID: 22311935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ceftaroline vs vancomycin for the treatment of acute pulmonary exacerbations in pediatric patients with cystic fibrosis.
    Branstetter J; Searcy H; Benner K; Yarbrough A; Crowder C; Troxler B
    Pediatr Pulmonol; 2020 Dec; 55(12):3337-3342. PubMed ID: 32803907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ceftaroline versus vancomycin for treatment of acute pulmonary exacerbations of cystic fibrosis in adults.
    Esquivel MD; Monogue ML; Smith GS; Finklea JD; Sanders JM
    J Glob Antimicrob Resist; 2022 Mar; 28():67-70. PubMed ID: 34936925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bacteremia due to Methicillin-Resistant Staphylococcus aureus: An Update on New Therapeutic Approaches.
    Holubar M; Meng L; Alegria W; Deresinski S
    Infect Dis Clin North Am; 2020 Dec; 34(4):849-861. PubMed ID: 33011050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ceftaroline fosamil salvage therapy: an option for reduced-vancomycin-susceptible MRSA bacteraemia.
    Espedido BA; Jensen SO; van Hal SJ
    J Antimicrob Chemother; 2015 Mar; 70(3):797-801. PubMed ID: 25406295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multicenter Observational Study of Ceftaroline Fosamil for Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.
    Zasowski EJ; Trinh TD; Claeys KC; Casapao AM; Sabagha N; Lagnf AM; Klinker KP; Davis SL; Rybak MJ
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27895012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ceftaroline pharmacodynamic activity versus community-associated and healthcare-associated methicillin-resistant Staphylococcus aureus, heteroresistant vancomycin-intermediate S. aureus, vancomycin-intermediate S. aureus and vancomycin-resistant S. aureus using an in vitro model.
    Zhanel GG; Rossnagel E; Nichol K; Cox L; Karlowsky JA; Zelenitsky S; Noreddin AM; Hoban DJ
    J Antimicrob Chemother; 2011 Jun; 66(6):1301-5. PubMed ID: 21429940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model.
    Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ
    J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methicillin-resistant Staphylococcus aureus epidural abscess treated with ceftaroline fosamil salvage therapy.
    Bucheit J; Collins R; Joshi P
    Am J Health Syst Pharm; 2014 Jan; 71(2):110-3. PubMed ID: 24375602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro activity of meropenem/piperacillin/tazobactam triple combination therapy against clinical isolates of Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus pseudintermedius and vancomycin-resistant Enterococcus spp.
    Yoneda A; Thänert R; Burnham CD; Dantas G
    Int J Antimicrob Agents; 2020 Feb; 55(2):105864. PubMed ID: 31870598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of Vancoplus versus ceftriaxone against cephalosporin resistance MRSA strain in experimental meningitis model.
    Soni A; Chaudhary M; Dwivedi VK; Kumar S; Shrivastava SM
    Cardiovasc Hematol Disord Drug Targets; 2010 Jun; 10(2):138-42. PubMed ID: 20350284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of ceftaroline versus vancomycin in an experimental foreign-body and systemic infection model caused by biofilm-producing methicillin-resistant Staphylococcus epidermidis.
    Domínguez-Herrera J; López-Rojas R; Smani Y; Labrador-Herrera G; Pachón J
    Int J Antimicrob Agents; 2016 Dec; 48(6):661-665. PubMed ID: 28128094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimicrobial Activity of Ceftaroline Tested against Staphylococcus aureus from Surgical Skin and Skin Structure Infections in US Medical Centers.
    Sader HS; Farrell DJ; Flamm RK; Jones RN
    Surg Infect (Larchmt); 2016 Aug; 17(4):443-7. PubMed ID: 26990170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model.
    Jacqueline C; Caillon J; Le Mabecque V; Miègeville AF; Hamel A; Bugnon D; Ge JY; Potel G
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3397-400. PubMed ID: 17591849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the Presence and Characterization of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Level Resistance Among Bloodstream Isolates of Methicillin-Resistant
    Ozmen Capin BB; Tekeli A; Karahan ZC
    Microb Drug Resist; 2020 Mar; 26(3):238-244. PubMed ID: 31545160
    [No Abstract]   [Full Text] [Related]  

  • 40. Activity of Telavancin against Staphylococcus aureus Isolates, Including Those with Decreased Susceptibility to Ceftaroline, from Cystic Fibrosis Patients.
    Roch M; Varela MC; Taglialegna A; Rose WE; Rosato AE
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29914961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.